Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1999-07-30
2000-12-26
McKane, Joseph
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514331, 514408, 514429, 514646, 544165, 546229, 546232, 546235, 548577, 560535, 564326, 252104, A61K 31535, A61K 31135, C07D41304, C07D21126
Patent
active
061660132
ABSTRACT:
Compounds having Formula I ##STR1## are useful for modulating the glucocorticoid receptor in a mammal. Also disclosed are pharmaceutical compositions comprising compounds of Formula I and methods of treating immune, autoimmune, inflammatory, adrenal imbalance, cognitive and behavioral diseases in a mammal.
REFERENCES:
patent: 4152341 (1979-05-01), Jones et al.
patent: 5112867 (1992-05-01), Kinoshita et al.
A. Nieto, et al, Biochemistry International, 1990, vol. 21, No. 2, pp. 305-311, "In Vivo Estrogenic and Antiestrogenic Activity of Phenolphthalein and Derivative Compounds".
Nieto, et al., Biochemistry International, 1990, vol. 21, No. 2, 305-311.
Greene, T.W. & Wuts, P.G.M. (1991) Protective Groups in Organic Synthesis (2.sup.nd ed.) New York: John Wiley & Sons.
Edward B. Roche, Bioreversible Carries in Drug Design, American Pharmaceutical Association and Pergamon Press, 1987.
S. M. Berge, et al., J. Pharmaceutical Sciences, 1977, 66:1-19.
Anal. Biochem, 1970, 37, 244-252.
Summers, M.D., Smith, G.E., A Manual of Methods for Baculovirus Vectors and Insect Cell Culture Procedures, Tex. Agric. Exp. Stn. [Bull], 1987, No. 155.
Wecksler, W.R., Norman, A.W., An Hydroxylapatite Batch Assay for the Quantitation of 1a, 25-Dihydroxyvitamin D3-Receptor Complexes, Anal. Biochem. 1979, 92, 314-323.
Chen, Y., et al., Relationship Between the Inhibition Constant (Ki) and the Cnecentration of Inhibitor Which Causes 50% Inhibition (IC50) of an Enzymatic Reaction, Biochem. Pharmacol., 1973, 22, 3099-3108.
DeBlasi, A., et al., Calculating Receptor Number from Binding Experiments Using Same Compound as Radioligand and Competitor, TIPS 1989, 10, 227-229.
Pham, T.A., et al., Ligand-Dependent and Independent Function of the Transactivation Regions of the Human Estrogen Receptor in Yeast, Mol. Endocrinol. 1992, 6, 1043-1050.
Loose, D., Ketoconazole Binds to Glucocorticoid Receptors and Exhibits Glucocorticoid Antagonist Activity in Cultured Cells, Journal of Clinical Investigation, US, vol. 72, Jul. 1, 1983, pp. 404-408.
Coghlan Michael J.
Luly Jay R.
Schkeryantz Jeffrey M.
Wang Alan X.
Abbott Laboratories
McKane Joseph
Pope Lawrence S.
Sackey Ebenezer
LandOfFree
Glucocortiocoid-selective agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Glucocortiocoid-selective agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Glucocortiocoid-selective agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-995072